Aditx Therapeutics, Inc.
11161 Anderson Street, Suite 105-10014
Loma Linda, CA 92354
June 17, 2020
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Paul Fischer Irene Paik |
Re: | Aditx Therapeutics, Inc. Registration Statement on Form S-1, as amended File No. 333-235933 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Aditx Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Daylight Time, on Thursday, June 18, 2020, or as soon thereafter as possible.
Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Respectfully submitted, | ||
ADITX THERAPEUTICS, INC. | ||
By: | /s/ Amro Albanna | |
Name: Amro Albanna | ||
Title: Chief Executive Officer |